Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with chronic myelocytic leukemia (a type of blood cancer also known as CML)
Who may not be able to join:
- You have had a stem cell or bone marrow transplant for your CML and have not received a type of targeted drug treatment called a TKI (tyrosine kinase inhibitor) (confirm with trial site)
- You are unwilling or unable to sign the consent form agreeing to take part in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marc BERGER, MD, University Hospital, Clermont-Ferrand
Phone: 04 73 75 11 95
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clinical and biological data collection
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.